Eton Pharmaceutcials, Inc. Common Stock (ETON) is a publicly traded Healthcare sector company. As of July 17, 2026, ETON trades at $37.96 with a market cap of $1.05B and a P/E ratio of -221.79. ETON moved -3.39% today. Year to date, ETON is +119.93%; over the trailing twelve months it is +167.75%. Its 52-week range spans $11.09 to $39.48. Analyst consensus is strong buy with an average price target of $48.50. Rallies surfaces ETON's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Rallies tracks the latest ETON news, catalysts, market updates, source links, and AI summaries when news is available.
| Metric | Value |
|---|---|
| Price | $37.96 |
| Market Cap | $1.05B |
| P/E Ratio | -221.79 |
| EPS | $-0.17 |
| Dividend Yield | 0.00% |
| 52-Week High | $39.48 |
| 52-Week Low | $11.09 |
| Volume | 377.73K |
| Avg Volume | 0 |
| Revenue (TTM) | $79.95M |
| Net Income | $-4.60M |
| Gross Margin | 53.46% |
3 analysts cover ETON: 0 strong buy, 3 buy, 0 hold, 0 sell, 0 strong sell. Consensus rating is strong buy. Average price target: $48.50.